NewsStable nanovesicles for the delivery of microRNA in cancer
treatment

4th February 2022by admin0
https://nfusion-tech.com/wp-content/uploads/2022/02/stable-nanovesicles-for-the-delivery-of-microrna-in-cancertreatment_61fe46496a4a0.jpeg

Researchers at ICMAB present a study on new
nanovesicles, known as quatsomes, which have been successfully
engineered to encapsulate and deliver microRNAs for the treatment
of tumors. These nanovesicles are produced by a simple GMP
compliant process, an unavoidable requirement for the clinical use
of new drug candidates. The study, published in Small, has been
highlighted in the Women in Materials Science issue of Advanced
Materials.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2022 New Fusion All Rights Reserved

      Designed by FallingBrick